Yukinobu Ichikawa

591 total citations
54 papers, 426 citations indexed

About

Yukinobu Ichikawa is a scholar working on Immunology, Rheumatology and Physiology. According to data from OpenAlex, Yukinobu Ichikawa has authored 54 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 19 papers in Rheumatology and 16 papers in Physiology. Recurrent topics in Yukinobu Ichikawa's work include Salivary Gland Disorders and Functions (15 papers), Systemic Lupus Erythematosus Research (12 papers) and Myasthenia Gravis and Thymoma (8 papers). Yukinobu Ichikawa is often cited by papers focused on Salivary Gland Disorders and Functions (15 papers), Systemic Lupus Erythematosus Research (12 papers) and Myasthenia Gravis and Thymoma (8 papers). Yukinobu Ichikawa collaborates with scholars based in Japan, United States and Australia. Yukinobu Ichikawa's co-authors include S Arimori, Masatoshi Takaya, Jerry C. Daniels, Junko Moriuchi, Hiroaki Shimizu, Emilio B. González, Joseph L. Jorizzo, Prapand Apisarnthanarax, Frank C. Schmalstieg and Tito Cavallo and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of the American Academy of Dermatology and Cellular Immunology.

In The Last Decade

Yukinobu Ichikawa

51 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukinobu Ichikawa Japan 12 102 99 79 73 73 54 426
Marta Rozans United States 8 84 0.8× 81 0.8× 191 2.4× 57 0.8× 86 1.2× 13 465
Masatoshi Takaya Japan 14 118 1.2× 111 1.1× 117 1.5× 71 1.0× 41 0.6× 51 401
Eva Simmons-OʼBrien United States 6 58 0.6× 109 1.1× 66 0.8× 54 0.7× 19 0.3× 7 429
R Rabinowitz Israel 11 131 1.3× 116 1.2× 18 0.2× 25 0.3× 21 0.3× 43 460
S. Rist France 9 80 0.8× 272 2.7× 173 2.2× 107 1.5× 33 0.5× 17 521
Ajay Ajmani United States 13 138 1.4× 129 1.3× 30 0.4× 106 1.5× 109 1.5× 29 523
William Godfrey United States 11 25 0.2× 56 0.6× 36 0.5× 36 0.5× 45 0.6× 16 392
Yasuyuki Kamata Japan 11 193 1.9× 125 1.3× 45 0.6× 39 0.5× 81 1.1× 30 455
B. Manger Germany 10 66 0.6× 350 3.5× 87 1.1× 47 0.6× 52 0.7× 20 523
M Binaghi France 12 38 0.4× 106 1.1× 20 0.3× 95 1.3× 56 0.8× 35 518

Countries citing papers authored by Yukinobu Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Yukinobu Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukinobu Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukinobu Ichikawa more than expected).

Fields of papers citing papers by Yukinobu Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukinobu Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukinobu Ichikawa. The network helps show where Yukinobu Ichikawa may publish in the future.

Co-authorship network of co-authors of Yukinobu Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yukinobu Ichikawa. A scholar is included among the top collaborators of Yukinobu Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukinobu Ichikawa. Yukinobu Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishii, Makoto, et al.. (1998). Fatal Alveolar Hemorrhage in a Patient with Mixed Connective Tissue Disease Presenting Polymyositis Features.. Internal Medicine. 37(6). 554–560. 9 indexed citations
2.
Ichikawa, Yukinobu, et al.. (1997). Molecular markers of coagulation and fibrinolysis as indicators for the disease activity of rheumatoid arthritis. 7(3). 173–181. 1 indexed citations
3.
Kawada, Hiroshi, et al.. (1996). Clinical significance of LEA-1 expression in adult acute myeloid leukemia. Leukemia Research. 20(4). 327–332. 10 indexed citations
4.
Ichikawa, Yukinobu, et al.. (1995). Psychological stress, disease activity and functional disability in patients with rheumatoid arthritis : a comparison with other chronic rheumatic or autoimmune disease patients. 6(1). 9–17. 3 indexed citations
5.
Inoko, Hidetoshi, et al.. (1994). Combinations of HLA-DPBl and HLA-DQB1 Alleles Determine Susceptibility to Early-Onset Myasthenia Gravis in Japan. Autoimmunity. 19(1). 49–54. 20 indexed citations
6.
Kawada, Hiroshi, et al.. (1994). Flow cytometric analysis of cell-surface antigen expressions on acute myeloid leukemia cell populations according to their cell-size. Leukemia Research. 18(1). 29–35. 5 indexed citations
7.
Hosaka, Takashi, Takayuki Aoki, & Yukinobu Ichikawa. (1994). Emotional States of Patients with Hematological Malignancies: Preliminary Study. Japanese Journal of Clinical Oncology. 24(4). 186–90. 19 indexed citations
8.
Kawada, Hiroshi, et al.. (1993). Acquisition of CD13 and CD33 Expression at Relapse on Acute Myeloid Leukemia Cells with an Unusual Phenotype: MPO+CD13-CD33-.. Internal Medicine. 32(9). 733–736. 3 indexed citations
9.
Ichikawa, Yukinobu, et al.. (1992). Serum Apolipoprotein H Levels in Systemic Lupus Erythematosus Are Not Influenced by Antiphospholipid Antibodies. Lupus. 1(3). 145–149. 8 indexed citations
10.
Ichikawa, Yukinobu, et al.. (1992). Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma. Clinical Immunology and Immunopathology. 62(1). 91–96. 15 indexed citations
11.
Moriuchi, Junko, Yukinobu Ichikawa, Masatoshi Takaya, et al.. (1991). Association of the complement allele c4aq0 with primary Sjögren's syndrome in japanese patients. Arthritis & Rheumatism. 34(2). 224–227. 7 indexed citations
12.
Ichikawa, Yukinobu, Hiroaki Shimizu, & S Arimori. (1991). "Yellow nail syndrome" and rheumatoid arthritis.. PubMed. 16(5-6). 203–9. 10 indexed citations
13.
Yamauchi, Kunihiko, Yutaka Suzuki, Yukinobu Ichikawa, Masatoshi Takaya, & S Arimori. (1988). Abnormalities of pulmonary blood flow during cold exposure in systemic lupus erythematosus. Nuclear Medicine Communications. 9(6). 423–430. 1 indexed citations
14.
Ichikawa, Yukinobu, et al.. (1987). High‐Dose Gammaglobulin Therapy of Generalized Myasthenia Gravis. Annals of the New York Academy of Sciences. 505(1). 868–871. 17 indexed citations
15.
Arimori, S, Junko Moriuchi, Yukinobu Ichikawa, et al.. (1987). Immunogenetics of Myasthenia Gravis Using HLA‐DNA Typing. Annals of the New York Academy of Sciences. 505(1). 790–792. 1 indexed citations
16.
Moriuchi, Junko, Yukinobu Ichikawa, Masatoshi Takaya, et al.. (1986). Association between HLA and Sjögren's syndrome in Japanese patients. Arthritis & Rheumatism. 29(12). 1518–1521. 24 indexed citations
17.
Ichikawa, Yukinobu, Emilio B. González, & Jerry C. Daniels. (1982). Suppressor cells of mitogen-induced lymphocyte proliferation in the peripheral blood of patients with common variable hypogammaglobulinemia. Clinical Immunology and Immunopathology. 25(2). 252–263. 8 indexed citations
18.
Ichikawa, Yukinobu, Masatoshi Takaya, & S Arimori. (1980). Circulating immune complexes in Sjögren's syndrome.. PubMed. 5(4). 367–74. 1 indexed citations
19.
Yamauchi, Kunihiko, et al.. (1980). Correlation between postsialographical changes of salivary isoamylase levels in serum and histopathological findings in sublingual glands in patients with Sjögren's syndrome.. PubMed. 5(2). 187–93. 1 indexed citations
20.
Ichikawa, Yukinobu, et al.. (1978). Clinical Studies on Patients with Systemic Lupus Erythematosus Associated with Sjogren's Syndrome. 3(4). 241–250. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026